
A couple thoughts on the Walgreen, Caremark spat
As you ve probably heard, Walgreens announced yesterday it won t fill prescriptions from patients who have CVS Caremark as their PB...

Materials, nanotechnology, iPhone app
Science news links for June 3rd through June 8th, including my latest contributions to Materials Today magazine:Nanotechnology fights c...

Success with cisgenics in forestry offers new tools for biotechnology
CORVALLIS, Ore. Forestry scientists at Oregon State University have demonstrated for the first time that the growth rate and other...

Protein could heal erectile dysfunction after cancer surgery
CHICAGO After men have surgery to remove a cancerous prostate gland, up to 80 percent of them will lose the ability to have an erec...

Hungary Exposure Weighs on Eastern Europe ETFs
In recent weeks, the fiscal health of Europe has dominated headlines of the financial presses and moved to the forefront of many invest...

Not Sold on AVI BioPharma... Yet
Avi BioPharma, Inc. (AVII) is back on the radar of late, after releasing some positive news reports. On Monday morning Avi announced t...

Study finds young men more vulnerable to relationship ups and downs than women
Winston-Salem, NC Contrary to popular belief, the ups and downs of romantic relationships have a greater effect on the mental healt...

June Gloom Envelopes the Market
Here in Santa Barbara, where Sabrient is headquartered, June Gloom is that time of year when the marine layer and murky fog last...

Ipilimumab (And Progress Against Cancer)
This time last year, Medarex made all sorts of headlines with their antibody ipilimumab. A press release from the Mayo Clinic made it s...
.gif)
Environmental Economics
Paul Kedrosky's Infectious Greed
Jeff Matthews Is Not Making This Up
TechCrunch
Trader Mike